Table 5.
The changes of glucose, HbA1c and insulin in fasting blood according to group†
| Placebo (n = 27) | BNR17 (n = 24) | p value§ | |
|---|---|---|---|
| Glucose (mg/dl) | |||
| Week 0 | 99.0 (93.0, 112.0) | 101.5 (98.0, 105.5) | 0.4499 |
| Week 8 | 99.0 (92.0, 106.0) | 97.5 (94.5, 102.0) | 0.6985 |
| ΔWeek 8–0 | −2.0 (−5.0, 5.0) | −3.0 (−8.0, 0.5) | 0.307 |
| p value‡ | 0.4402 | 0.0138 | |
| HbA1c (%) | |||
| Week 0 | 5.5 (5.3, 5.8) | 5.4 (5.3, 5.8) | 0.5184 |
| Week 8 | 5.5 (5.3, 5.7) | 5.5 (5.2, 5.7) | 0.5308 |
| Δ Week 8–0 | 0.0 (−0.1, 0.2) | 0.0 (−0.1, 0.1) | 0.9772 |
| p value‡ | 0.788 | 0.7894 |
†Median, interquartile range (25%, 75%) in parentheses (all such values). ‡Within-group comparisons using Wilcoxon signed rank test. §Between-group comparisons using Wilcoxon rank sum test.